Sarawak has reached a new milestone in advanced cardiac care with the successful completion of the first EPi-Sense hybrid ...

Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...

ABT wins FDA approval for its Volt PFA System for AFib, paving the way for U.S. launches and EU expansion after earlier CE Mark clearance.

Medtronic tops the list of the largest cardio device companies, with cardiovascular technology proving a major growth driver.

The King Abdullah University Hospital (KAUH) has performed its first catheter-based cardiac ablation procedures for the treatment of cardiac arrhythmias, using advanced electrophysiology and cardiac ...

The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for ...

Abbott will soon enter the competitive U.S. pulsed field ablation (PFA) market, having just received FDA approval for its ...

The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...

Abbott Laboratories is set to roll out its Volt PFA System in the U.S., following federal approval, and continue expanding ...

Abbott (NYSE: ABT) announced today that the FDA approved its Volt pulsed field ablation (PFA) system to treat patients with AFib.